APA

Hoskins P., Swenerton K., Manji M., Wong F., O'Reilly S., McMurtrie E., Le N., Acker B. & Le Richer J. (1994). 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Chicago

Hoskins P.J, Swenerton K.D, Manji M, Wong F, O'Reilly S.E, McMurtrie E.J, Le N, Acker B and Le Richer J. 1994. 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Harvard

Hoskins P., Swenerton K., Manji M., Wong F., O'Reilly S., McMurtrie E., Le N., Acker B. and Le Richer J. (1994). 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

MLA

Hoskins P.J, Swenerton K.D, Manji M, Wong F, O'Reilly S.E, McMurtrie E.J, Le N, Acker B and Le Richer J. 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1994.